Literature DB >> 21939732

PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population.

Zhen Yang1, Jie Wen, Qin Li, Xiaoming Tao, Zi Ye, Min He, Weiwei Zhang, Ying Huang, Lili Chen, Charlotte Ling, Shen Qu, Renming Hu.   

Abstract

Oxidative stress has been suggested to contribute to the development of non-alcoholic fatty liver disease (NAFLD). Peroxisome proliferator-activated receptor gamma (PPAR-γ) heterozygous mice and Pro12Ala (C/G) polymorphism in PPARG exhibited increased resistance to oxidative stress. Smoking increases the production of reactive oxygen species, which could accelerates oxidative stress under overnutrition. To explore whether the C/G polymorphism, alone or in combination with smoking, may promote the development of non-alcoholic fatty liver, a case-control study was performed in 903 Chinese subjects. Among the study population, 436 patients with B-mode ultrasound-proven NAFLD (318 with steatosis hepatis I°, 90 with steatosis hepatis II° and 28 with steatosis hepatis III°) and 467 controls were genotyped by using TaqMan allelic discrimination assays. After adjusting for confounders, the C/C genotype significantly associated with NAFLD (OR=1.87, 95%CI 1.13-2.85, p=0.009); smoking was also an independent risk factor for NAFLD (OR=1.69, 95%CI 1.18-2.43, p=0.025). In addition, we found possible synergistic effects, the higher risk group (smokers with the C/C genotype) showed 3.75 times higher risk of NAFLD than the low-risk group (non-smokers with C/G genotype) in a multiple logistic analysis after adjusting for the confounders (p<0.001), but no departure from additivity was found. Our results indicated that the C/C genotype and smoking were significant independent risk factors for NAFLD. The possible synergistic effects of genotype and smoking may promote the development of NAFLD by aggravating oxidative stress, which supports the hypothesis that oxidative stress contributes to the development of NAFLD.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939732     DOI: 10.1016/j.mce.2011.09.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  A small supernumerary marker chromosome resulting in mosaic partial tetrasomy 4q26-q31.21 in a foetus with multiple congenital malformations.

Authors:  Zhi-Tao Zhang; Wen-Xu Qi; Cai-Xia Liu; Shao-Wei Yin; Yan Zhao; Jesse Li-Ling; Yuan Lv
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease.

Authors:  Chun Wang; Jianping Gong; Hao Wu
Journal:  Biomed Rep       Date:  2017-06-14

4.  The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease.

Authors:  Chuang-Yu Cao; Yu-Yuan Li; Yong-Jian Zhou; Yu-Qiang Nie; Yu-Jui Yvonne Wan
Journal:  Tohoku J Exp Med       Date:  2012-08       Impact factor: 1.848

5.  Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease.

Authors:  Zi Ye; Suijun Wang; Zhen Yang; Min He; Shuo Zhang; Weiwei Zhang; Jie Wen; Qin Li; Ying Huang; Xuanchun Wang; Bin Lu; Zhaoyun Zhang; Qing Su; Renming Hu
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

6.  Dual Outcomes of Rosiglitazone Treatment on Fatty Liver.

Authors:  Mingming Gao; Yongjie Ma; Mohammad Alsaggar; Dexi Liu
Journal:  AAPS J       Date:  2016-04-28       Impact factor: 4.009

7.  Meta-analysis of associations between the peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism and susceptibility to nonalcoholic fatty liver disease, rheumatoid arthritis, and psoriatic arthritis.

Authors:  Young Ho Lee; Sang-Cheol Bae; Gwan Gyu Song
Journal:  Genet Test Mol Biomarkers       Date:  2014-04-03

8.  Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?

Authors:  Paola Dongiovanni; Luca Valenti
Journal:  PPAR Res       Date:  2013-02-04       Impact factor: 4.964

9.  PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.

Authors:  Marion Peyrou; Pierluigi Ramadori; Lucie Bourgoin; Michelangelo Foti
Journal:  PPAR Res       Date:  2012-09-13       Impact factor: 4.964

10.  Endogenously increased n-3 PUFA levels in fat-1 transgenic mice do not protect from non-alcoholic steatohepatitis.

Authors:  Marie Liebig; Dirk Dannenberger; Brigitte Vollmar; Kerstin Abshagen
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.